These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21494077)

  • 1. A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.
    Lee D; Ki M; Lee A; Lee KR; Park HB; Kim CS; Yoon BY; Kim JH; Lee YS; Jeong SH
    Korean J Hepatol; 2011 Mar; 17(1):44-50. PubMed ID: 21494077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy.
    Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH
    Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
    Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
    World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis a in Lebanon: a changing epidemiological pattern.
    Sacy RG; Haddad M; Baasiri G; Khoriati A; Gerbaka BJ; Abu-Elyazeed R
    Am J Trop Med Hyg; 2005 Aug; 73(2):453-6. PubMed ID: 16103621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.
    Zhu Y; Yuan Z; Zhao Q; Chen G; Xu B
    Epidemiol Infect; 2013 Mar; 141(3):556-62. PubMed ID: 22687628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
    Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
    Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
    Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine.
    Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM
    J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory.
    Cho SE; Kim Y
    J Epidemiol; 2013; 23(4):270-4. PubMed ID: 23629647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing epidemiology of hepatitis A infection in Izmir, Turkey.
    Kurugol Z; Aslan A; Turkoglu E; Koturoglu G
    Vaccine; 2011 Aug; 29(37):6259-61. PubMed ID: 21763745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The age-specific seroprevalence of hepatitis A virus antibody in Korea].
    Song YB; Lee JH; Choi MS; Koh KC; Paik SW; Yoo BC; Choi YH; Sohn HJ; Lee KH; Rhee JC
    Korean J Hepatol; 2007 Mar; 13(1):27-33. PubMed ID: 17380072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis A incidence and hospital-based seroprevalence in Italy: a nation-wide study.
    Ansaldi F; Bruzzone B; Rota MC; Bella A; Ciofi degli Atti M; Durando P; Gasparini R; Icardi G;
    Eur J Epidemiol; 2008; 23(1):45-53. PubMed ID: 17978852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shifting seroepidemiology of hepatitis A in Japan, 1973-2003.
    Kiyohara T; Sato T; Totsuka A; Miyamura T; Ito T; Yoneyama T
    Microbiol Immunol; 2007; 51(2):185-91. PubMed ID: 17310086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
    Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
    Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
    J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.
    Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH
    Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of recent IgG anti-HAV prevalence between two hospitals in Seoul and Gyeonggi area].
    Kim TY; Sohn JH; Ahn SB; Son BK; Lee HL; Eun CS; Jeon YC; Han DS
    Korean J Hepatol; 2007 Sep; 13(3):363-9. PubMed ID: 17898552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of hepatitis A virus in Mumbai, and immunogenicity and safety of hepatitis A vaccine.
    Dhawan PS; Shah SS; Alvares JF; Kher A; Shankaran ; Kandoth PW; Sheth PN; Kamath H; Kamath A; Koppikar GV; Kalro RH
    Indian J Gastroenterol; 1998 Jan; 17(1):16-8. PubMed ID: 9465507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative hepatitis A seroepidemiology in 10 European countries.
    Kurkela S; Pebody R; Kafatos G; Andrews N; Barbara C; Bruzzone B; Butur D; Caplinskas S; Davidkin I; Hatzakis A; Hellenbrand W; Hesketh LM; Nardone A; Nemecek V; Pistol A; Sobotová Z; Vranckx R; Anastassopoulou CG
    Epidemiol Infect; 2012 Dec; 140(12):2172-81. PubMed ID: 22273572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of IgG anti-HAV in patients with chronic hepatitis B and in the general healthy population in Korea.
    Lee SH; Kim HS; Park KO; Park JW; Chun SY; Lim SJ; Cho HJ; Kim SJ; Park HW; Moon HK; Shin WG; Kim KH; Jang MK; Lee JH; Kim HY
    Korean J Hepatol; 2010 Dec; 16(4):362-8. PubMed ID: 21415579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.